New Trial Denied After Defense Verdict In Abbott Biliary Stent Trial

(May 20, 2016, 12:40 PM EDT) -- DALLAS — A Texas federal judge on May 18 denied a whistle-blower’s motion for a new trial in his False Claims Act case alleging that Abbott Laboratories Inc. promoted its biliary stents for off-label use in the vascular system (United States of America, ex rel. Kevin Colquitt v. Abbott Laboratories, et al., No. 06-1769, N.D. Texas).

(Order available. Document #28-160602-002R.)

Chief U.S. Judge Barbara M.G. Lynn of the Northern District of Texas said the jury’s April 7 defense verdict was not against the “great weight of...
To view the full article, register now.